vs
Side-by-side financial comparison of Clorox (CLX) and Moolec Science SA (MLEC). Click either name above to swap in a different company.
Clorox is the larger business by last-quarter revenue ($1.7B vs $2.6M, roughly 633.0× Moolec Science SA). Clorox runs the higher net margin — 9.4% vs -91.8%, a 101.2% gap on every dollar of revenue.
The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
CLX vs MLEC — Head-to-Head
Income Statement — Q2 2026 vs Q2 2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.6M |
| Net Profit | $157.0M | $-2.4M |
| Gross Margin | 43.2% | -25.5% |
| Operating Margin | — | -77.9% |
| Net Margin | 9.4% | -91.8% |
| Revenue YoY | 0.3% | — |
| Net Profit YoY | -15.6% | — |
| EPS (diluted) | $1.29 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | $2.6M | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.8B | — | ||
| Q4 23 | $2.0B | — |
| Q4 25 | $157.0M | — | ||
| Q2 25 | $332.0M | — | ||
| Q1 25 | $186.0M | — | ||
| Q4 24 | $193.0M | $-2.4M | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $216.0M | — | ||
| Q1 24 | $-51.0M | — | ||
| Q4 23 | $93.0M | — |
| Q4 25 | 43.2% | — | ||
| Q2 25 | 46.5% | — | ||
| Q1 25 | 44.6% | — | ||
| Q4 24 | 43.8% | -25.5% | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 46.5% | — | ||
| Q1 24 | 42.2% | — | ||
| Q4 23 | 43.5% | — |
| Q4 25 | — | — | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 14.1% | -77.9% | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | -2.3% | — | ||
| Q4 23 | 6.8% | — |
| Q4 25 | 9.4% | — | ||
| Q2 25 | 16.7% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 11.4% | -91.8% | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -2.8% | — | ||
| Q4 23 | 4.7% | — |
| Q4 25 | $1.29 | — | ||
| Q2 25 | $2.68 | — | ||
| Q1 25 | $1.50 | — | ||
| Q4 24 | $1.54 | $-0.06 | ||
| Q3 24 | $0.80 | — | ||
| Q2 24 | $1.74 | — | ||
| Q1 24 | $-0.41 | — | ||
| Q4 23 | $0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $227.0M | $1.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-125.0M | $2.8M |
| Total Assets | $5.6B | $31.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $227.0M | — | ||
| Q2 25 | $167.0M | — | ||
| Q1 25 | $226.0M | — | ||
| Q4 24 | $290.0M | $1.9M | ||
| Q3 24 | $278.0M | — | ||
| Q2 24 | $202.0M | — | ||
| Q1 24 | $219.0M | — | ||
| Q4 23 | $355.0M | — |
| Q4 25 | — | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | $-125.0M | — | ||
| Q2 25 | $321.0M | — | ||
| Q1 25 | $27.0M | — | ||
| Q4 24 | $-41.0M | $2.8M | ||
| Q3 24 | $60.0M | — | ||
| Q2 24 | $328.0M | — | ||
| Q1 24 | $91.0M | — | ||
| Q4 23 | $53.0M | — |
| Q4 25 | $5.6B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.5B | — | ||
| Q4 24 | $5.6B | $31.4M | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.8B | — | ||
| Q1 24 | $5.8B | — | ||
| Q4 23 | $5.9B | — |
| Q4 25 | — | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.56× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLX
| Health And Wellness | $643.0M | 38% |
| Household | $419.0M | 25% |
| Lifestyle | $321.0M | 19% |
| Other | $290.0M | 17% |
MLEC
Segment breakdown not available.
